Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Soeki

Showing results (11-20 of 177) with videos related to

Pageof 18
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|December 26, 2003
Elevated concentration of soluble vascular endothelial cadherin is associated with coronary atherosclerosisTakeshi Soeki, Yoshiyuki Tamura, Hisanori Shinohara, et al.
International Heart Journal|October 1, 2025
Impact of Atrial Fibrillation Accompanied by Sarcopenia and Cellular Edema on the Prevalence of Heart Failure in Elderly IndividualsAkihiro Tani, Takeshi Soeki, Kumiko Suto, et al.
Frontiers in Cardiovascular Medicine|November 12, 2016
Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic MouseHotimah Masdan Salim, Daiju Fukuda, Shusuke Yagi, et al.
Journal of the American College of Cardiology|February 15, 2005
C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarctionTakeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, et al.
Journal of Medical Ultrasonics (2001)|June 10, 2016
Short-term therapy with relatively low-dose cerivastatin improves endothelial function independently of its lipid-lowering effect: Evaluation of brachial artery vasodilatation using B-mode ultrasound imagingKoichi Sakabe, Nobuo Fukuda, Teru Nada, et al.
Cardiovascular Diabetology|February 4, 2014
Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic miceSachiko Matsumoto, Michio Shimabukuro, Daiju Fukuda, et al.
Journal of Cardiology|July 22, 2008
A case of neurogenic myocardial stunning presenting transient left ventricular mid-portion ballooning simulating atypical takotsubo cardiomyopathyKoji Yamaguchi, Tetsuzo Wakatsuki, Kenya Kusunose, et al.
Pacing and Clinical Electrophysiology : PACE|May 27, 2003
Relation of age and sex to atrial electrophysiological properties in patients with no history of atrial fibrillationKoichi Sakabe, Nobuo Fukuda, Takeshi Soeki, et al.
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|December 4, 2025
A novel mineralocorticoid receptor blocker, CS-3150, improves insulin resistance and reduces inflammation in db/db miceOyunbileg Bavuu, Daiju Fukuda, Uugantsetseg Munkhjargal, et al.
Scientific Reports|August 3, 2019
Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic micePhuong Tran Pham, Daiju Fukuda, Shusuke Yagi, et al.
Pageof 18

Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Circulation Journal : Official Journal of the Japanese Circulation Society|December 26, 2003
Elevated concentration of soluble vascular endothelial cadherin is associated with coronary atherosclerosisTakeshi Soeki, Yoshiyuki Tamura, Hisanori Shinohara, et al.
International Heart Journal|October 1, 2025
Impact of Atrial Fibrillation Accompanied by Sarcopenia and Cellular Edema on the Prevalence of Heart Failure in Elderly IndividualsAkihiro Tani, Takeshi Soeki, Kumiko Suto, et al.
Frontiers in Cardiovascular Medicine|November 12, 2016
Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic MouseHotimah Masdan Salim, Daiju Fukuda, Shusuke Yagi, et al.
Journal of the American College of Cardiology|February 15, 2005
C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarctionTakeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, et al.
Journal of Medical Ultrasonics (2001)|June 10, 2016
Short-term therapy with relatively low-dose cerivastatin improves endothelial function independently of its lipid-lowering effect: Evaluation of brachial artery vasodilatation using B-mode ultrasound imagingKoichi Sakabe, Nobuo Fukuda, Teru Nada, et al.
Cardiovascular Diabetology|February 4, 2014
Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic miceSachiko Matsumoto, Michio Shimabukuro, Daiju Fukuda, et al.
Journal of Cardiology|July 22, 2008
A case of neurogenic myocardial stunning presenting transient left ventricular mid-portion ballooning simulating atypical takotsubo cardiomyopathyKoji Yamaguchi, Tetsuzo Wakatsuki, Kenya Kusunose, et al.
Pacing and Clinical Electrophysiology : PACE|May 27, 2003
Relation of age and sex to atrial electrophysiological properties in patients with no history of atrial fibrillationKoichi Sakabe, Nobuo Fukuda, Takeshi Soeki, et al.
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|December 4, 2025
A novel mineralocorticoid receptor blocker, CS-3150, improves insulin resistance and reduces inflammation in db/db miceOyunbileg Bavuu, Daiju Fukuda, Uugantsetseg Munkhjargal, et al.
Scientific Reports|August 3, 2019
Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic micePhuong Tran Pham, Daiju Fukuda, Shusuke Yagi, et al.
Pageof 18